Publicacións en colaboración con investigadores/as de Hospital Universitario Central de Asturias (18)

2022

  1. Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

    IJC Heart and Vasculature, Vol. 38

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2016

  1. A single-institution analysis of the effect on local control of high-dose rate brachytherapy boost in a single 7 Gy fraction

    Revista de Senologia y Patologia Mamaria, Vol. 29, Núm. 2, pp. 63-68

2015

  1. Radiotherapyinduced breakthrough cancer pain: Is it possible to optimize its treatment?

    Revista de la Sociedad Espanola del Dolor, Vol. 22, Núm. 4, pp. 159-164

2013

  1. Survival of hematological patients after discharge from the intensive care unit: A prospective observational study

    Critical Care, Vol. 17, Núm. 6

2012

  1. Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer

    Radiation Oncology, Vol. 7, Núm. 1

2008

  1. Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 72, Núm. 2, pp. 421-432

2007

  1. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

    British Journal of Cancer, Vol. 97, Núm. 7, pp. 957-963

  2. Study of matrix metalloproteinases and their inhibitors in breast cancer

    British Journal of Cancer, Vol. 96, Núm. 6, pp. 903-911

2006

  1. Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance

    Breast Cancer Research and Treatment, Vol. 96, Núm. 1, pp. 63-72

2005

  1. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer

    International Journal of Biological Markers, Vol. 20, Núm. 2, pp. 103-111

  2. Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)

    Journal of Cancer Research and Clinical Oncology, Vol. 131, Núm. 11, pp. 701-714

  3. Expression and prognostic value of EGFR in invasive breast cancer

    Oncology Reports, Vol. 14, Núm. 6, pp. 1655-1663

  4. Tissue-Type plasminogen activator (tPA) in breast cancer: Relationship with clinicopathological parameters and prognostic significance

    Breast Cancer Research and Treatment, Vol. 90, Núm. 1, pp. 33-40

2003

  1. Significación clínica del contenido tumoral del receptor del factor de crecimiento epidérmico en el cáncer de mama

    Revista Espanola de Medicina Nuclear, Vol. 22, Núm. 6, pp. 386-394

2002

  1. Analysis of the cytosolic content of the pS2 protein in breast cancer

    Revista Espanola de Medicina Nuclear, Vol. 21, Núm. 1, pp. 28-33

1997

  1. Clinical significance of preoperative serum levels of CA 125 and TAG-72 in ovarian carcinoma

    International Journal of Biological Markers, Vol. 12, Núm. 3, pp. 112-117